Literature DB >> 777044

Infection with Streptococcus agalactiae in a London hospital.

F S Mhalu.   

Abstract

Streptococcus agalactiae is presently the commonest beta-haemolytic streptococcus isolated from clinical material in this hospital. Between October 1974 and March 1975, 81 patients with such infections were seen. Seventeen had urinary tract infections, six had septicaemia, and one neonate had meningitis. Three of those with septicaemia were neonates and two died. The organism was also found to be a cause of pyogenic skin conditions in five patients. Isolates from throat swabs in 12 patients, from sputum in four, and from the female genital tract in 18 were considered part of the normal flora. Human strains of Str. agalactiae were found to be biochemically different from animal strains.

Entities:  

Mesh:

Year:  1976        PMID: 777044      PMCID: PMC476053          DOI: 10.1136/jcp.29.4.309

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Emergence of group B streptococci in obstetric and perinatal infections.

Authors:  T M Reid
Journal:  Br Med J       Date:  1975-06-07

2.  Comparative studies of group "B" streptococci of human and bovine origin. I. Cultural and biochemical characters.

Authors:  A A EL GHOROURY
Journal:  Am J Public Health Nations Health       Date:  1950-10

3.  Editorial: Group B streptococci: a serious threat to the neonate.

Authors:  M Yow
Journal:  JAMA       Date:  1974-11-25       Impact factor: 56.272

4.  Transmission of group B streptococci among parturient women and their neonates.

Authors:  C J Baker; F F Barrett
Journal:  J Pediatr       Date:  1973-12       Impact factor: 4.406

5.  Frequencies of streptococci of groups A, B, C, D, and G in urethra and cervix swab specimens from patients with suspected gonococcal infection.

Authors:  K K Christensen; P Christensen; L Flamholc; T Ripa
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-08

6.  The rapid recognition of Lancefield group B haemolytic streptococci.

Authors:  R J Fallon
Journal:  J Clin Pathol       Date:  1974-11       Impact factor: 3.411

  6 in total
  13 in total

Review 1.  Streptococcus agalactiae mastitis: a review.

Authors:  G P Keefe
Journal:  Can Vet J       Date:  1997-07       Impact factor: 1.008

2.  Synergistic hemolysis phenomenon shown by an alpha-toxin-producing Clostridium perfingens and streptococcal CAMP factor in presumptive streptococcal grouping.

Authors:  S M Gubash
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

3.  Characterization and incidence of pigment production by human clinical group B streptococci.

Authors:  K Merritt; N J Jacobs
Journal:  J Clin Microbiol       Date:  1978-07       Impact factor: 5.948

4.  Multiplication of contaminant bacteria in urine and interpretation of delayed culture.

Authors:  D B Wheldon; M Slack
Journal:  J Clin Pathol       Date:  1977-07       Impact factor: 3.411

5.  Group B streptococcal soft tissue infections beyond the neonatal period.

Authors:  J M McCarty; J Haber
Journal:  West J Med       Date:  1987-11

6.  Streptococcus agalactiae in urinary tract infections.

Authors:  F S Mhalu
Journal:  Postgrad Med J       Date:  1977-04       Impact factor: 2.401

7.  Streptococcus agalactiae as a urinary tract pathogen in males and non-pregnant females.

Authors:  B Girgitzova; N Minkov; B Zozikov
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

8.  Faecal carriage of group B streptococci.

Authors:  A K Islam; E Thomas
Journal:  J Clin Pathol       Date:  1980-10       Impact factor: 3.411

9.  Evaluation of rapid methods of identifying group B streptococci.

Authors:  S A Waitkins
Journal:  J Clin Pathol       Date:  1980-03       Impact factor: 3.411

10.  Comparative genomics analysis of Streptococcus agalactiae reveals that isolates from cultured tilapia in China are closely related to the human strain A909.

Authors:  Guangjin Liu; Wei Zhang; Chengping Lu
Journal:  BMC Genomics       Date:  2013-11-11       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.